/Companies

Synereca Pharmaceuticals

Oklahoma City, US · Delaware corporation

Find your way into Synereca Pharmaceuticals

Sign up to see every warm intro you have to Synereca Pharmaceuticals

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Synereca Pharmaceuticals team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Founders & leadership

BW
Bennett W. LoveNamed on SEC filing
CI
Clayton I. DuncanNamed on SEC filing
SF
Scott F. SingletonNamed on SEC filing
MC
Mark CorriganNamed on SEC filing
RE
Richard E. GammansNamed on SEC filing
SM
Scott MeachamNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$600K disclosed across 1 round · 2017

▶$600KraisedAug 2017 · 10 investors · Other Health Care
Rule 506(b)
Officers, directors & promoters on the filing
  • Bennett W. LoveDirector
  • Clayton I. DuncanExecutive Officer, Director
  • Scott F. SingletonDirector
  • Mark CorriganDirector
  • Richard E. GammansExecutive Officer, Promoter
  • Scott MeachamDirector
Offering amount
$1.2M
Amount sold
$600K
First sale
Aug 2017
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Synereca Pharmaceuticals raised?
Synereca Pharmaceuticals has disclosed $600K raised across 1 round.
Where is Synereca Pharmaceuticals headquartered?
Synereca Pharmaceuticals is headquartered in Oklahoma City, US.